Liquidia Technologies Inc

NASDAQ:LQDA USA Biotechnology
Market Cap
$3.21 Billion
Market Cap Rank
#4676 Global
#2898 in USA
Share Price
$36.86
Change (1 day)
+3.25%
52-Week Range
$11.99 - $46.63
All Time High
$46.63
About

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The comp… Read more

Liquidia Technologies Inc (LQDA) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.443x

Based on the latest financial reports, Liquidia Technologies Inc (LQDA) has a cash flow conversion efficiency ratio of -0.443x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.77 Million) by net assets ($22.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Liquidia Technologies Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Liquidia Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Liquidia Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Liquidia Technologies Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Liquidia Technologies Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Liquidia Technologies Inc from 2016 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $77.28 Million $-93.42 Million -1.209x -37.56%
2023-12-31 $47.29 Million $-41.56 Million -0.879x -177.98%
2022-12-31 $90.42 Million $-28.59 Million -0.316x +39.37%
2021-12-31 $65.27 Million $-34.03 Million -0.521x +31.53%
2020-12-31 $71.09 Million $-54.14 Million -0.762x +44.87%
2019-12-31 $34.95 Million $-48.28 Million -1.382x +18.89%
2018-12-31 $18.69 Million $-31.83 Million -1.703x -336.26%
2017-12-31 $-33.69 Million $-24.29 Million 0.721x -5.68%
2016-12-31 $-18.25 Million $-13.95 Million 0.764x --